<code id='8E1A14A809'></code><style id='8E1A14A809'></style>
    • <acronym id='8E1A14A809'></acronym>
      <center id='8E1A14A809'><center id='8E1A14A809'><tfoot id='8E1A14A809'></tfoot></center><abbr id='8E1A14A809'><dir id='8E1A14A809'><tfoot id='8E1A14A809'></tfoot><noframes id='8E1A14A809'>

    • <optgroup id='8E1A14A809'><strike id='8E1A14A809'><sup id='8E1A14A809'></sup></strike><code id='8E1A14A809'></code></optgroup>
        1. <b id='8E1A14A809'><label id='8E1A14A809'><select id='8E1A14A809'><dt id='8E1A14A809'><span id='8E1A14A809'></span></dt></select></label></b><u id='8E1A14A809'></u>
          <i id='8E1A14A809'><strike id='8E1A14A809'><tt id='8E1A14A809'><pre id='8E1A14A809'></pre></tt></strike></i>

          knowledge

          knowledge

          author:knowledge    Page View:5
          Ron Wyden (left), Mike Crapo (right) -- health policy coverage from STAT
          Draft legislation authored by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho) includes several measures to regulate how pharmacy benefit managers are paid by health plans to negotiate with drugmakers. Pete Marovich-Pool/Getty Images

          WASHINGTON — A key Senate health care panel has developed a plan to tackle reforms to middlemen in the pharmacy drug payment system, according to bill text obtained by STAT.

          The draft legislation, authored by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho), includes several measures to regulate how pharmacy benefit managers are paid by health plans to negotiate with drugmakers.

          advertisement

          The most significant measure is a bill from Sens. Bob Menendez (D-N.J.) and Marsha Blackburn (R-Tenn.) that would prohibit PBMs from getting any income outside of service fees, and prohibits those service fees from being related to drugs’ list prices.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          knowledge

          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more
          Ethical issues complicate the benefits of medical crowdfunding
          Ethical issues complicate the benefits of medical crowdfunding

          APStockMedicalcrowdfunding—usingsocialnetworksandmediatoraisefundsformedicaltreatment—isgrowinginpop

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          Coloradans with cystic fibrosis could lose access to Trikafta

          Illustration:STAT;Source:BusinessWire/APIwaslivingontheprecipiceofend-stagediseasewhenIenrolledinthe